Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Akeso Health Sciences is a nutraceutical company specializing in the development of science-based dietary supplements for migraine relief and neurological health. The company is best known for its MigreLief product line, which was formulated by Chief Science Officer Curt Hendrix to address the underlying nutritional deficiencies associated with migraine headaches. MigreLief products utilize a "Triple Therapy" approach, combining high-dose riboflavin, magnesium, and a proprietary feverfew extract known as Puracol. The company offers specialized formulations for adults, children, and women experiencing menstrual migraines, as well as an acute support formula. Akeso Health Sciences emphasizes clinical research and high-quality ingredient sourcing, positioning its products as natural alternatives to traditional pharmaceutical migraine treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MigreLief.